4475 Wayburne Drive
Unit 210
Burnaby, BC V5G 4X4
Canada
https://filament.health
Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 11
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Benjamin Lightburn | Co-Founder, CEO & Chairman | 129.26k | N/A | 1987 |
Mr. Warren Duncan CPA | Chief Financial Officer | 110.79k | N/A | 1991 |
Mr. Jon Conlin | Corp. Sec. & Director | N/A | N/A | 1986 |
Ms. Lisa Ranken | Chief Operating Officer | N/A | N/A | 1984 |
Mr. Ryan Moss | Chief Science Officer | N/A | N/A | N/A |
Ms. Anna Cordon | Director of Communications | N/A | N/A | N/A |
Mr. Jeff Fellows | Head of Regulatory | N/A | N/A | N/A |
Filament Health Corp. operates as a clinical-stage natural psychedelic drug development company. The company propagates psychedelic plants and fungi; conducts genetic research; develops manufacturing technology; generates intellectual property; conducts in-house trials; and distributes drug candidates to drug developers, researchers, and other licensed parties. Filament Health Corp. is headquartered in Burnaby, Canada.
Filament Health Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.